Uncontrolled diabetes mellitus: A risk factor for post COVID fibrosis

Parul Mrigpuri; Sonal Sonal; Sonam Spalgais; Nitin Goel; Balakrishnan Menon; Raj Kumar

doi:10.4081/monaldi.2021.1607

https://doi.org/10.4081/monaldi.2021.1607

Parul Mrigpuri | parul57_mrigpuri@yahoo.com Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India. https://orcid.org/0000-0001-7723-4866
Sonal Sonal Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India.
Sonam Spalgais Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India. https://orcid.org/0000-0001-7116-2486
Nitin Goel Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India. https://orcid.org/0000-0001-5155-8985
Balakrishnan Menon Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India.
Raj Kumar Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of New Delhi, India.

Abstract

Dear Editor,

The Corona virus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the Wuhan province of china in December 2019. COVID-19 spread to the world in a short time and was declared as public health emergency of international concern by World Health Organization...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 2020;8:807-15.

Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract 2020;162:108142.

Fraser E. Long term respiratory complications of Covid-19. BMJ 2020;370:m3001.

Vasarmidi E, Tsitoura E, Spandidos DA, et al. Pulmonary fibrosis in the aftermath of the COVID-19 era (Review). Exp Ther Med 2020;20:2557-60.

Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary fibrosis in COVID-19 survivors: Predictive factors and risk reduction strategies. Pulm Med 2020;2020:1-10.